期刊文献+

糖尿病肾病大鼠肾组织乙酰肝素酶的基因表达及意义

下载PDF
导出
摘要 目的检测糖尿病肾病大鼠肾组织HPA的基因表达,探讨其在糖尿病肾病蛋白尿发生中的作用。方法采用一次性腹腔注射链脲佐菌素的方法构建糖尿病大鼠模型。动物随机分为健康对照组(n=6)、糖尿病6周组(DM6周,n=10)和糖尿病12周组(DM12周,n=10)。应用实时荧光定量PCR技术检测各组大鼠肾组织HPA的基因表达并分析其与蛋白尿的相关性。结果①DM组HPA基因表达与健康对照组相比均显著增高(P<0.001)。②HPA基因表达与大鼠尿蛋白之间存在正相关趋势(r=0.595,P<0.001)。结论 HPA基因在糖尿病肾病中表达增高,可能参与了糖尿病肾病蛋白尿的发生。
出处 《中国医药指南》 2013年第34期347-348,共2页 Guide of China Medicine
  • 相关文献

参考文献5

  • 1Wu VY,Wilson B,Cohen MP. Disturbances in glomerular basement membrane glycosamonoglycans in experimental diabetes[J].{H}DIABETES,1987,(06):679-683.
  • 2Reddi AS. Prevention of albuminuria by captopril in diabetic rats[J].{H}General Pharmacology,1991,(02):323-328.
  • 3Levidiotis V,Kanellis J,Ierino FL. Increased expression of heparanase in puromycin aminonucleoside nephrosis[J].{H}Kidney International,2001,(04):1287-1296.
  • 4唐琳,王玉华,刘章锁,肖静,窦艳娜,董吉.乙酰肝素酶在糖尿病肾病大鼠蛋白尿发生中的作用[J].中华肾脏病杂志,2008,24(4):277-281. 被引量:4
  • 5van den Hoven MJ,Rops AL,Bakker MA. Increased expre-ssion of heparanase in overt diabetic nephropathy[J].{H}Kidney International,2006,(12):2100-2108.

二级参考文献12

  • 1Jeansson M, Haraldsson B. Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycandegrading enzymes. J Am Soc Nephrol, 2003,14:1756-1765.
  • 2Conde-Knape K. Heparan sulfate proteoglyeans in experimental models of diabetes: a role for perleean in diabetes complications. Diabetes Metab Res Rev,2001,17: 412-421.
  • 3Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med, 1999,5:793-802.
  • 4Levidiotis V, Freeman C, Punler M, et al. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. J Am Soc Nephrol, 2004,15:2882-2892.
  • 5Levidiotis V, Kanellis J, Ierino FL, et ah Increased expression of heparanase in puromycin aminonucleoside nephrosis. Kidney lnt, 2001,60:1287-1296.
  • 6Levidiotis V, Freeman C, Tikellis C, et al. Heparanase inhibition reduces proteinuria in a model of accelerated antiglomerular basement membrane antibody disease. Nephrology (Carlton), 2005,10:167-173.
  • 7Katz A, Van-Dijk DJ, Aingorn H, et al. Involvement of human heparanase in the pathogenesis of diabetic nephropathy. Isr Med Assoc J, 2002,4:996-1002.
  • 8Shafat I, Zcharia E, Nisman B, et al. An ELISA method for the detection and quantification of human heparanase. Biochem Biophys Res Commun, 2006,341:958-963.
  • 9van den Hoven MJ, Rops AL, Bakker MA, et al. Increased expression of heparanase in overt diabetic nephropathy. Kidney Int, 2006,70:2100-2108.
  • 10Han J, Mandal AK, Hiebert LM. Endothelial cell injury by high glucose and heparanase is prevented by insulin, heparin and basic fibroblast growth factor. Cardiovasc Diabetol, 2005,4:12.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部